when was retatrutide created This weight-loss drug hasn't been approved by the FDA. Doctors are prescribing it anyway Retatrutide produces up to 30.3%
Description
With options like Ozempic, Wegovy, and compounded formulations, GLP-1 agonists provide flexibility and convenience for individuals seeking help with obesity and metabolic conditions

Levenga J, Wong H, Milstead RA, Keller BN, LaPlante LE, Hoeffer CA

doi: 10.1007/s40265-022-01746-8

These may indicate serious complications requiring urgent assessment

This matters because a compound that weakly hits three targets would be less useful than one that strongly hits two
